Literature DB >> 17548038

Merkel cell carcinomas.

Vy Dinh1, Lynn Feun, George Elgart, Niramol Savaraj.   

Abstract

Merkel cell carcinoma (MCC) is a rare and extremely aggressive skin cancer that arises from primary neural cells. It presents most commonly in the elderly and immunocompromised patients. Pathologically, MCC should be distinguished from extrapulmonary small cell lung cancer or metastatic small cell lung cancer or a small cell variant of melanoma. The prognosis is based largely on the stage of disease at the time of presentation. Therapeutic options for MCC include wide resection with or without adjuvant radiotherapy or chemotherapy. Novel therapies based on the understanding of the molecular aspects of MCC are currently being explored.

Entities:  

Mesh:

Year:  2007        PMID: 17548038     DOI: 10.1016/j.hoc.2007.04.008

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

1.  Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays.

Authors:  Yanis L Tolstov; Diana V Pastrana; Huichen Feng; Jürgen C Becker; Frank J Jenkins; Stergios Moschos; Yuan Chang; Christopher B Buck; Patrick S Moore
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

2.  Recurrence of Merkel cell carcinoma in the gastrointestinal tract: a case report.

Authors:  Rasikh Tuktamyshov; Dhanpat Jain; Philip M Ginsburg
Journal:  BMC Res Notes       Date:  2015-05-07

Review 3.  Merkel cell carcinoma of the upper extremity: case report and an update.

Authors:  Michail Papamichail; Ioannis Nikolaidis; Nicolas Nikolaidis; Chryssoula Glava; Ioannis Lentzas; Konstantinos Marmagkiolis; Kriton Karassavsa; Michail Digalakis
Journal:  World J Surg Oncol       Date:  2008-03-07       Impact factor: 2.754

4.  Merkel cell polyomavirus and extrapulmonary small cell carcinoma.

Authors:  Kathryn C Hourdequin; Joel A Lefferts; Jeoffry B Brennick; Marc S Ernstoff; Gregory J Tsongalis; J Marc Pipas
Journal:  Oncol Lett       Date:  2013-07-23       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.